Detalhe da pesquisa
1.
Immune Sensing of Synthetic, Bacterial, and Protozoan RNA by Toll-like Receptor 8 Requires Coordinated Processing by RNase T2 and RNase 2.
Immunity
; 52(4): 591-605.e6, 2020 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294405
2.
Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA.
Nat Immunol
; 16(10): 1025-33, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26343537
3.
A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2'O-Methylated Self RNA.
Immunity
; 43(1): 41-51, 2015 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26187414
4.
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Int J Cancer
; 152(2): 308-319, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054558
5.
Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets.
J Virol
; 96(16): e0055922, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916513
6.
Retinoic Acid-Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection.
J Infect Dis
; 226(12): 2079-2088, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861054
7.
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma.
J Neurooncol
; 156(2): 365-375, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882287
8.
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
Int J Cancer
; 148(7): 1695-1707, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113214
9.
Extracellular Vesicle Separation Techniques Impact Results from Human Blood Samples: Considerations for Diagnostic Applications.
Int J Mol Sci
; 22(17)2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34502122
10.
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet
; 393(10172): 678-688, 2019 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782343
11.
Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study.
Graefes Arch Clin Exp Ophthalmol
; 258(2): 311-318, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31863395
12.
Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature.
Int J Mol Sci
; 21(19)2020 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33003586
13.
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 20(10): 1444-1453, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488360
14.
Direct RIG-I activation in human NK cells induces TRAIL-dependent cytotoxicity toward autologous melanoma cells.
Int J Cancer
; 144(7): 1645-1656, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30230526
15.
Effect of transcutaneous vagus nerve stimulation on muscle activity in the gastrointestinal tract (transVaGa): a prospective clinical trial.
Int J Colorectal Dis
; 34(3): 417-422, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30519842
16.
Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.
Immunity
; 31(1): 25-34, 2009 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19576794
17.
Cutting Edge: The RIG-I Ligand 3pRNA Potently Improves CTL Cross-Priming and Facilitates Antiviral Vaccination.
J Immunol
; 196(6): 2439-43, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819202
18.
RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection.
Mol Ther
; 25(9): 2093-2103, 2017 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28760668
19.
Who is a 'healthy subject'?-consensus results on pivotal eligibility criteria for clinical trials.
Eur J Clin Pharmacol
; 73(4): 409-416, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28064353
20.
Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.
EMBO J
; 31(1): 201-13, 2012 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22036947